Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma

Wu,Ting‑Ting; Chen,Chen; Chen,Shi‑Ming; Xu,Yong; Wang,Yan; Chen,Zhe; Wang,Fei; Xiao,Bo‑Kui; Tao,Ze‑Zhang

doi:10.3892/ol.2014.2689

Nuclear translocation of telomerase reverse transcriptase is a critical process in lymphatic metastasis of nasopharyngeal carcinoma

Authors:
- Ting‑Ting Wu
- Chen Chen
- Shi‑Ming Chen
- Yong Xu
- Yan Wang
- Zhe Chen
- Fei Wang
- Bo‑Kui Xiao
- Ze‑Zhang Tao
View Affiliations

Affiliations: Department of Otolaryngology‑Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Otolaryngology‑Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: November 7, 2014 https://doi.org/10.3892/ol.2014.2689
Pages: 265-269

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Telomerase reverse transcriptase (TERT) is the predominant functional unit of telomerase and maintains the telomere length and the stability of chromosomes. Recently, TERT has been shown to be a critical factor in a number of other biological processes, including cell proliferation and cancer metastasis. In addition, although numerous studies have been conducted, the subcellular localization of the TERT protein and the association of such with cancer metastasis remains unclear. To investigate the involvement of TERT in in vivo metastasis, quantum dots‑based immunofluorescence and western blot analysis were conducted to detect changes in the subcellular localization of TERT in human nasopharyngeal carcinoma (NPC) tissues and metastatic lymph nodes. To further investigate, metastatic and non‑metastatic models of NPC were generated using 5‑8F (high metastasis capability) and 6‑10B (low metastasis capability) cell lines, respectively. It was found that TERT protein was overexpressed in NPC tissue samples and metastatic lymph nodes and TERT was predominantly located in the cytoplasm of primary NPC tissues, while TERT was predominantly located in the nucleus of the metastatic lymph nodes. The ratio of cytoplasmic TERT/nuclear TERT for the primary tumor of the 6‑10B cell line was almost six‑fold higher than that of the metastatic lymph nodes of the 5‑8F cell line. TERT translocation from the cytoplasm to nucleus may present a critical step in the lymphatic metastasis of NPC. Thus, TERT translocation may be more useful than TERT expression level and telomerase activity for predicting the metastasis of NPC.

View Figures

View References

1	Harley CB: Telomerase and cancer therapeutics. Nat Rev Cancer. 8:167–179. 2008. View Article : Google Scholar : PubMed/NCBI
2	Liu JP, Chen SM, Cong YS, Nicholls C, Zhou SF, Tao ZZ and Li H: Regulation of telomerase activity by apparently opposing elements. Ageing Res Rev. 9:245–256. 2010. View Article : Google Scholar : PubMed/NCBI
3	Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science. 279:349–352. 1998. View Article : Google Scholar : PubMed/NCBI
4	Yang C, Przyborski S, Cooke MJ, et al: A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells. 26:850–863. 2008. View Article : Google Scholar : PubMed/NCBI
5	Blagoev KB: Cell proliferation in the presence of telomerase. PLoS One. 4:e46222009. View Article : Google Scholar : PubMed/NCBI
6	Chang B, Myatt L and Cui XL: Loss of proliferative capacity in a retroviral immortalized human uterine smooth muscle cell line derived from leiomyoma is restored by hTERT overexpression. Reprod Sci. 16:1062–1071. 2009. View Article : Google Scholar : PubMed/NCBI
7	Bollmann FM: The many faces of telomerase: emerging extratelomeric effects. Bioessays. 30:728–732. 2008. View Article : Google Scholar : PubMed/NCBI
8	Li N, Yang R, Zhang W, Dorfman H, Rao P and Gorlick R: Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer. 115:4795–4806. 2009. View Article : Google Scholar : PubMed/NCBI
9	Techangamsuwan S, Haas L, Rohn K, Baumgärtner W and Wewetzer K: Distinct cell tropism of canine distemper virus strains to adult olfactory ensheathing cells and Schwann cells in vitro. Virus Res. 144:195–201. 2009. View Article : Google Scholar : PubMed/NCBI
10	Cong Y and Shay JW: Actions of human telomerase beyond telomeres. Cell Res. 18:725–732. 2008. View Article : Google Scholar : PubMed/NCBI
11	Pellicciotta I, Cortez-Gonzalez X, Sasik R, Reiter Y, Hardiman G, Langlade-Demoyen P and Zanetti M: Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res. 68:8085–8093. 2008. View Article : Google Scholar : PubMed/NCBI
12	Wang S and Zhu J: The hTERT gene is embedded in a nuclease-resistant chromatin domain. J Biol Chem. 279:55401–55410. 2004. View Article : Google Scholar : PubMed/NCBI
13	Zhang C, Guo X, Jiang G, et al: CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer. 123:998–1004. 2008. View Article : Google Scholar : PubMed/NCBI
14	Liu K, Hodes RJ and Weng Np: Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol. 166:4826–4830. 2001. View Article : Google Scholar : PubMed/NCBI
15	Wong JM, Kusdra L and Collins K: Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol. 4:731–736. 2002. View Article : Google Scholar : PubMed/NCBI
16	Kyo S, Masutomi K, Maida Y, et al: Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol. 163:859–867. 2003. View Article : Google Scholar : PubMed/NCBI
17	Lepreux S, Doudnikoff E, Aubert I, Bioulac-Sage P, Bloch B and Martin-Negrier ML: Cytoplasmic expression of human telomerase catalytic protein (hTERT) in neutrophils: an immunoelectron microscopy study. Ultrastruct Pathol. 32:178–183. 2008. View Article : Google Scholar : PubMed/NCBI
18	Chen C, Xia HS, Gong YP, et al: The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials. 31:8818–8825. 2010. View Article : Google Scholar : PubMed/NCBI
19	Haendeler J, Hoffmann J, Rahman S, Zeiher AM and Dimmeler S: Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett. 536:180–186. 2003. View Article : Google Scholar : PubMed/NCBI
20	Kawauchi K, Ihjima K and Yamada O: IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3′-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J Immunol. 174:5261–5269. 2005. View Article : Google Scholar : PubMed/NCBI
21	Saretzki G: Telomerase, mitochondria and oxidative stress. Exp Gerontol. 44:485–492. 2009. View Article : Google Scholar : PubMed/NCBI
22	Maida Y, Yasukawa M, Furuuchi M, et al: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature. 461:230–235. 2009. View Article : Google Scholar : PubMed/NCBI
23	Minamino T, Mitsialis SA and Kourembanas S: Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol. 21:3336–3342. 2001. View Article : Google Scholar : PubMed/NCBI